• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives Isoquinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives

Introduction to 3-((Trimethylsilyl)ethynyl)isoquinoline (CAS No. 86521-11-1)

3-((Trimethylsilyl)ethynyl)isoquinoline, identified by its Chemical Abstracts Service (CAS) number 86521-11-1, is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This molecule, characterized by its isoquinoline core appended with a terminal (trimethylsilyl)ethynyl group, exhibits unique structural and electronic properties that make it a valuable intermediate in the synthesis of various bioactive molecules and advanced materials.

The isoquinoline scaffold is a prominent heterocyclic system widely recognized for its presence in numerous natural products and pharmacologically active compounds. Its aromaticity, coupled with the electron-withdrawing nature of the nitrogen atom, contributes to its versatility in medicinal chemistry. The introduction of a (trimethylsilyl)ethynyl moiety at the 3-position of the isoquinoline ring enhances the compound's reactivity, making it particularly useful in cross-coupling reactions such as Sonogashira couplings, which are pivotal in constructing carbon-carbon bonds in organic synthesis.

Recent advancements in the pharmaceutical industry have highlighted the potential of 3-((Trimethylsilyl)ethynyl)isoquinoline as a key building block in the development of novel therapeutic agents. Its ability to serve as a precursor for more complex molecules has been leveraged in the design of small-molecule inhibitors targeting various biological pathways. For instance, derivatives of this compound have been explored as inhibitors of enzymes involved in cancer progression, demonstrating promising preclinical efficacy.

The (trimethylsilyl)ethynyl group not only facilitates synthetic modifications but also imparts stability to the molecule, which is crucial for pharmaceutical applications where metabolic stability is a critical factor. This stability ensures that the compound can undergo multiple synthetic transformations without degradation, allowing for greater flexibility in drug design.

In materials science, 3-((Trimethylsilyl)ethynyl)isoquinoline has been investigated for its potential use in organic electronics. The conjugated system of isoquinoline, combined with the electron-deficient nature of the ethynyl group, makes it an attractive candidate for applications in organic light-emitting diodes (OLEDs), organic photovoltaics (OPVs), and other optoelectronic devices. Research has shown that incorporating this compound into polymer or small-molecule semiconductors can enhance charge transport properties, leading to improved device performance.

The synthesis of 3-((Trimethylsilyl)ethynyl)isoquinoline typically involves multi-step reactions starting from commercially available precursors. A common approach includes the Sonogashira coupling between 3-bromoisoquinoline and terminal acetylenes followed by silylation using trimethylchlorosilane and a suitable base. This synthetic route highlights the importance of (trimethylsilyl)ethynyl groups in facilitating high-yielding transformations.

Recent studies have also explored the photophysical properties of 3-((Trimethylsilyl)ethynyl)isoquinoline, revealing its potential as a photosensitizer or fluorescent probe. The compound's ability to absorb light across multiple wavelengths and emit with high quantum yields makes it suitable for applications in bioimaging and photocatalysis. Additionally, its photochemical stability under various conditions further enhances its utility in these fields.

The pharmaceutical applications of this compound extend beyond cancer therapy. Researchers have been investigating its role in developing treatments for neurological disorders, where isoquinoline derivatives have shown promise as neuroprotective agents. The structural features of 3-((Trimethylsilyl)ethynyl)isoquinoline allow it to interact with specific biological targets, potentially modulating pathways associated with neurodegeneration.

In conclusion, 3-((Trimethylsilyl)ethynyl)isoquinoline (CAS No. 86521-11-1) is a versatile and highly functional molecule with broad applications across pharmaceutical chemistry and materials science. Its unique structural features enable it to serve as a crucial intermediate in synthetic chemistry, while its electronic properties make it valuable for optoelectronic applications. As research continues to uncover new methodologies and applications, this compound is poised to play an increasingly significant role in advancing both therapeutic and technological innovations.

• 86521-07-5(2-((Trimethylsilyl)ethynyl)quinoline)
• 884494-41-1(Trimethyl-[2-(4-methylpyridin-2-yl)ethynyl]silane)
• 86521-10-0(1-((Trimethylsilyl)ethynyl)isoquinoline)
• 75867-44-6(Pyridine,2,6-bis[2-(trimethylsilyl)ethynyl]-)
• 86521-05-3(trimethyl-[2-(2-pyridyl)ethynyl]silane)
• 761426-51-1(Pyridine, 2-methyl-4-[(trimethylsilyl)ethynyl]-)
• 497258-59-0(2-[2-(trimethylsilyl)ethynyl]-1H-Indole)
• 496840-15-4(Pyridine, 2-ethynyl-6-[(trimethylsilyl)ethynyl]-)
• 872428-46-1(5-Methyl-2-trimethylsilanylethynylpyridine)
• 656800-40-7(Pyridine, 2-methyl-6-[(trimethylsilyl)ethynyl]-)